Background Continuous femoral nerve block has been
Introduction
The recent introduction of the Patient Protection and Affordable Care Act has made hospital and surgeon reimbursement subject to penalty if patients are not satisfied with the quality of their care after surgery [11] . With more than 50% of patients citing postoperative pain as their primary fear before surgery [19] , and pain control being one of several important quality measures involved in the Patient Protection and Affordable Care Act, there is a compelling argument for the surgeon and anesthesiologist to focus on postoperative pain control after major surgeries such as TKA.
Continuous femoral nerve block has been shown to decrease opioid use and improve postoperative pain scores [3, 5, 6, 8, 9, 14, 15, 18] . These blocks have also been shown to decrease length of stay and complications and increase early knee flexion [3, 5, 6, 8, 14, 15, 18] . However, several studies have raised the concern that continuous femoral nerve block may delay patient ambulation and increase the risk of falls during the postoperative period [10, 16] . To date, few studies specifically address the effect of continuous femoral nerve block on early ambulation after TKA [4, 14, 15] .
The primary objective of this study was to determine whether continuous femoral nerve block, as a component of multimodal analgesia, prevented early ambulation after TKA. The secondary objective was to report other adverse effects such as patient falls with the use of a continuous femoral nerve block.
Patients and Method
After institutional review board approval, we retrospectively reviewed a consecutive series of 77 patients treated with continuous femoral nerve block after primary TKA at a single location. All TKAs were performed at an academic orthopaedic specialty hospital between January 2011 and January 2013 by a single surgeon (CLP). All patients at this location receive a continuous femoral nerve block, unless the patient declined a block or if it was contraindicated by allergy. Because no patients during this period had contraindications or refused a block, all were included for review. Patients' records were reviewed for admission date, discharge date, discharge location, age, primary diagnosis, surgical anesthetic type, nerve block type and concentration, American Society of Anesthesiologists (ASA) score, total anesthesia time, height, weight, anesthesiologist, ambulation distances, stairs ascended, falls, reoperations, and any other block-associated complications.
The cross-section of patients was similar to the overall practice of the surgeon in regard to age, sex, and height but differed in weight and body mass index (Table 1) Anesthesia and perioperative pain management at this location are under direct supervision of a single anesthesiologist (JDS). All nerve blocks were placed preoperatively using ultrasound guidance (Fig. 1) . Patients received detailed instruction on the risks and benefits of peripheral nerve block before surgery and anesthesia. The continuous femoral nerve block catheters were positioned deep to the fascia iliaca and 1 cm lateral to the femoral nerve. All patients received an initial injection of preservative-free bupivacaine (30 mL) followed by an infusion of bupivacaine 0.125% at a rate of 5 mL/hour for 48 hours. All sciatic nerve blocks were also placed using ultrasound guidance. These blocks were performed using a single injection of 0.125% bupivacaine (30 mL) approximately 1 cm medial to the sciatic nerve within the popliteal space. Before surgery, each patient was tested for temperature and light touch sensation over the anterior thigh and foot to confirm sensory loss in the distributions of the femoral and sciatic nerves. On the day of surgery and twice daily thereafter, a physical therapist consulted on each patient in an attempt to have them stand and ambulate. A knee immobilizer and frontwheeled walker were used during ambulation as a precaution for possible quadriceps weakness. The knee immobilizer was continued until 72 hours after surgery (24 hours after the block was removed). All patients were also evaluated for motor function in the distribution of the sciatic nerve before ambulation. Those patients with weakness in the tibial or peroneal nerve distribution were not allowed to ambulate until motor function had recovered. In addition to scheduled physical therapy, patients were allowed to ambulate as desired with the assistance of the floor nurse; however, because distance during these sessions was not recorded, this
was not included in the analysis. The electronic record was reviewed to identify specific rehabilitation events such as the time of first ambulation, the distances ambulated, the ability to ascend stairs, and the incidence of patient falls or other complications related to ambulation. 
Discussion
Previous studies have demonstrated that femoral nerve block can provide decreased opioid use, improved postoperative pain scores, and decreased length of stay while avoiding many of the complications associated with other techniques such as continuous epidural analgesia [3, 5, 6, 8, 14, 15, 18] . However, concerns remain that femoral nerve block will prevent early ambulation and increase the number of patient falls after surgery [1, 7, 10, 12] . In our cohort, all patients were able to ambulate by postoperative Day 1 and 45% (35 of 77) of patients were able to ambulate on the day of surgery. In this small retrospective series, we observed no falls or serious complications related to use of the blocks, although we took active steps to prevent falls, including the use of a knee immobilizer for ambulation while the block was in effect.
As a retrospective case series, our study has characteristic limitations in its design. The major limitation of this study is the small size of the series, which was too small to quantify uncommon events such as falls or permanent nerve injury and thus, the safety of this analgesic approach cannot be compared with more traditional opioid-based techniques based on this study alone. In addition, despite the favorable outcomes in our series when compared with earlier trials [8, 14, 15] , our study lacks a control group and thus, we are unable to compare the beneficial effect of our multimodal pain management protocol with traditional opioid-based techniques. Another concern is selection bias.
The majority of TKAs performed by the senior surgeon during the study period (78%), including the high-risk patients, were performed at a separate tertiary care facility and not at the study site where the patients in this series received their care; thus, this study population was different from the overall population of primary TKAs in some important ways, including weight and body mass index (Table I) , and this likely resulted in some selection bias.
However, the variability in anesthesia care at our tertiary Among existing publications, there is considerable disparity about the effect of femoral nerve block on early ambulation after TKA. Although some authors have reported mean ambulation distances of 102 to 337 feet in the first 2 days after surgery [4, 14, 15] , others note substantial limitations in early ambulation. For example, Seet et al. [16] reported no ambulation until at least 60 hours after surgery. Similarly, Kandasami et al. [10] reported that 70% of their patients were unable to mobilize until postoperative Day 2 ( Table 2 ). An important component of our treatment protocol facilitating ambulation is the use of dilute bupivacaine with the intention of preserving motor function. It is well known that bupivacaine exhibits a dose-response effect that progresses from analgesia to dense motor block as its concentration is increased and although it is desirable to use motor-sparing concentrations of bupivacaine, the duration of action of such concentrations is limited [13] . Thus, we used a continuous femoral nerve block infusion to control both Clinical Orthopaedics and Related Research* Early ambulation is an important component for optimal recovery after TKA. We believe our outcomes to be noteworthy in that all patients were able to ambulate on postoperative Day 1 and thereafter. Our findings suggest that continuous femoral nerve block using low-dose bupivacaine does not prevent ambulation in the early postoperative period. In this series, patients had documented sensory effects in the distribution of the femoral nerve but were not adversely affected by any associated motor block. This may be attributed to use of a knee immobilizer while the block is in place along with training and diligence of the floor staff.
The overall complication rate of femoral nerve catheters has generally ranged from 1.5% to 8.0% [7, 10, 17, 20] .
This risk can be reduced through the use of ultrasound guidance, which decreases the risk of vascular or other mechanical injury during insertion [2] . Moreover, the risk of postoperative falls with continuous femoral nerve block has been reported to be 0.7% to 3.0% with reoperation required in up to 0.4% of cases [7, 10, 17, 20] . In our group of patients, there were no reported falls despite having all patients ambulate at least twice daily. However, our study did not include adequate numbers to address this issue specifically.
Although several previous publications have warned surgeons about the detrimental effects on postoperative ambulation, this analysis demonstrates that continuous femoral nerve block with dilute bupivacaine (0.125%) can be successfully used in conjunction with multimodal analgesia after TKA in a way that does not prevent early ambulation. By taking active steps to prevent in-hospital falls, including the use of a knee immobilizer for ambulation while the block is functioning, patients can benefit from the analgesia provided by the block and still ambulate early after TKA.
